Holding Lantus Based on Blood Glucose Levels
Lantus (insulin glargine) should be held or reduced when fasting self-monitored blood glucose (FSBS) falls below 70 mg/dL (3.9 mmol/L), which is the established hypoglycemia alert threshold, and dose adjustments should be made to prevent recurrent hypoglycemia at this level. 1
Hypoglycemia Thresholds and Action Points
The current diabetes care guidelines define a clear hierarchy of hypoglycemia levels that should guide insulin management decisions:
Level 1 hypoglycemia occurs at glucose <70 mg/dL (3.9 mmol/L) but ≥54 mg/dL (3.0 mmol/L) - this is the alert value requiring treatment with fast-acting carbohydrates 1
Level 2 hypoglycemia occurs at glucose <54 mg/dL (3.0 mmol/L) - this represents clinically significant hypoglycemia requiring immediate treatment 1
Level 3 hypoglycemia is a severe event with altered mental/physical status requiring assistance from another person 1
Specific Insulin Dose Adjustment Recommendations
When FSBS values fall into hypoglycemic ranges, basal insulin should be adjusted using established titration algorithms:
For FSBS <4.4 mmol/L (79 mg/dL): Decrease insulin glargine by 2 units 2
For FSBS 4.4-7.0 mmol/L (79-126 mg/dL): No change in dose 2
Target FSBS range: Most titration studies aim for 4.4-5.6 mmol/L (79-101 mg/dL) or up to 7.0 mmol/L (126 mg/dL) depending on individual patient factors 3, 4, 5
Critical Clinical Considerations
Hypoglycemia unawareness or recurrent level 2/3 hypoglycemia mandates raising glycemic targets to strictly avoid hypoglycemia for at least several weeks, which helps partially reverse hypoglycemia unawareness and reduces future episode risk. 1
Several high-risk situations warrant particular vigilance and potential dose reduction or holding of Lantus:
Fasting states: During prolonged fasting (religious observance, medical procedures), basal insulin should be reduced to approximately 40% of total daily dose to prevent hypoglycemia 6
Food insecurity: Patients with unreliable food access have increased hypoglycemia-related emergency visits and require more conservative dosing 1
Elderly patients and young children: These populations have reduced ability to recognize and communicate hypoglycemic symptoms, requiring individualized lower glycemic targets 1
Practical Management Algorithm
When encountering low FSBS values with Lantus:
At 70 mg/dL (3.9 mmol/L): Treat with 15g fast-acting carbohydrates immediately; reduce next Lantus dose by 10-20% 1
Below 54 mg/dL (3.0 mmol/L): Treat hypoglycemia aggressively; hold or significantly reduce (by 20-40%) next Lantus dose pending reassessment 1
Recurrent hypoglycemia pattern: Reevaluate entire insulin regimen and raise glycemic targets 1
The FDA label for Lantus does not specify exact glucose thresholds for holding the medication, but emphasizes that dose adjustments should target fasting plasma glucose ≤100 mg/dL while avoiding hypoglycemia. 7
Common Pitfalls to Avoid
Do not wait for severe hypoglycemia before adjusting doses - act at the 70 mg/dL threshold 1
Avoid overbasalization - if fasting glucose remains elevated despite high basal insulin doses (>0.5-1.0 units/kg/day), consider adding prandial insulin rather than continuing to escalate basal insulin 8
Ensure patients recheck glucose 15 minutes after treating hypoglycemia and repeat carbohydrate ingestion if needed 1
Educate patients that glucagon should be available for those at risk of severe hypoglycemia, and caregivers should know how to administer it 1